Full length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays

Παρόμοια τεκμήρια

• Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1
  ανά: Parry, Chris M., κ.ά.
  Έκδοση: (2009)
• Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
  ανά: Sutherland, Katherine A., κ.ά.
  Έκδοση: (2015)
• Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
  ανά: Sutherland, Katherine A., κ.ά.
  Έκδοση: (2016)
• Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
  ανά: Sutherland, Katherine A., κ.ά.
  Έκδοση: (2015)
• Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length gag–protease genes
  ανά: Sutherland, Katherine A., κ.ά.
  Έκδοση: (2014)